76 related articles for article (PubMed ID: 11850682)
1. Effect of Domperidone on the Bromocriptine-Induced Antihypertensive Action in Hypertensive Patients.
Luchsinger A; Velasco M; Arbona E; Forte P; Gómez J; Sukerman M; Urbina A; Pieretti OH
Am J Ther; 1995 Jun; 2(6):388-394. PubMed ID: 11850682
[TBL] [Abstract][Full Text] [Related]
2. Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensive patients.
Luchsinger A; Grilli M; Forte P; Morales E; Velasco M
Int J Clin Pharmacol Ther; 1995 Sep; 33(9):509-12. PubMed ID: 8520809
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat.
Nagahama S; Chen YF; Oparil S
J Pharmacol Exp Ther; 1984 Feb; 228(2):370-5. PubMed ID: 6363675
[TBL] [Abstract][Full Text] [Related]
4. Metoclopramide and domperidone block the antihypertensive effect of bromocriptine in hypertensive patients.
Luchsinger A; Grilli M; Velasco M
Am J Ther; 1998 Mar; 5(2):81-8. PubMed ID: 10099042
[TBL] [Abstract][Full Text] [Related]
5. [Hemodynamic and biological effects of bromocriptine in essential hypertension].
Allain H; Daubert JC; Massart C; van den Driessche J; Gouffault J
Arch Mal Coeur Vaiss; 1982 Sep; 75(9):951-62. PubMed ID: 6816179
[TBL] [Abstract][Full Text] [Related]
6. Effects of dopaminergic antagonists on dopamine-induced cardiovascular and insulin secretion actions in hypertensive patients.
Forte P; Martin G; Luchsinger A; Hernandez O; Romero E; Velasco M
Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):404-6. PubMed ID: 8225687
[TBL] [Abstract][Full Text] [Related]
7. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
Lahlou S
Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583
[TBL] [Abstract][Full Text] [Related]
8. Metoclopramide-Induced Vascular Hyperreactivity: A Comparative Study Between Normotensive and Hypertensive Subjects.
Blanco M; Jelambi I; Hurtado N; Velasco M
Am J Ther; 1996 May; 3(5):371-374. PubMed ID: 11862274
[TBL] [Abstract][Full Text] [Related]
9. [How do we explain the antihypertensive effect of bromocriptine? Clinical and experimental contribution].
Chamontin B; Montastruc JL; Rascol A
Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1181-5. PubMed ID: 6151826
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic influence on the cardiovascular response to exercise in normotensive and hypertensive subjects.
Velasco M; Corujo M; Valery J; Luchsinger A; Morales E
Int J Clin Pharmacol Ther; 1995 Sep; 33(9):504-8. PubMed ID: 8520808
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of dopaminergic agonists on cardiovascular, renal, and renin-angiotensin systems in hypertensive patients.
Luchsinger A; Velasco M; Urbina A; Morillo J; Romero E; Alvarez R; Pieretti OH
J Clin Pharmacol; 1992 Jan; 32(1):55-60. PubMed ID: 1346790
[TBL] [Abstract][Full Text] [Related]
12. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and Hormonal Effects of Domperidone, A Peripheral Dopaminergic Blocker, in Bromocriptine-Treated Hypertensive Patients.
Velasco M; Arreaza R; Luchsinger A; Gómez J; Morales E
Am J Ther; 1995 Jul; 2(7):451-454. PubMed ID: 11850690
[TBL] [Abstract][Full Text] [Related]
14. [Hypotensive action of a dopaminergic agonist, bromocriptine, in the dog].
Montastruc JL; Rascol A; Montastruc P
Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():91-8. PubMed ID: 6794532
[TBL] [Abstract][Full Text] [Related]
15. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
Mahmud A; Mahgoub M; Hall M; Feely J
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
[TBL] [Abstract][Full Text] [Related]
16. Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension.
Nussberger J; Gradman AH; Schmieder RE; Lins RL; Chiang Y; Prescott MF
Int J Clin Pract; 2007 Sep; 61(9):1461-8. PubMed ID: 17590217
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
18. The role of the adrenal medulla in the antihypertensive action of bromocriptine in neurogenic hypertensive dogs.
Montastruc JL; Montastruc P
J Pharmacol; 1983; 14(2):183-7. PubMed ID: 6865444
[TBL] [Abstract][Full Text] [Related]
19. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
[TBL] [Abstract][Full Text] [Related]
20. Aliskiren: renin inhibitor for hypertension management.
Cheng JW
Clin Ther; 2008 Jan; 30(1):31-47. PubMed ID: 18343241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
